Publicacións nas que colabora con Jorge Salgado Fernández (15)

2023

  1. Percutaneous Management of Aortic Root Rupture After Balloon-Expandable TAVR

    JACC: Case Reports, Vol. 26

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2020

  1. Impact of covid-19 outbreak and public lockdown on st-segment elevation myocardial infarction care in Spain

    Cardiology Journal

  2. Impacto de la implementación de un programa de cateterismo ambulatorio en un centro de alto volumen

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 317-317

  3. Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 10

2013

  1. Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: Insights from a cohort of 1391 patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 2, Núm. 1, pp. 19-26

  2. Long-term prognostic benefit of field triage and direct transfer of patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 111, Núm. 12, pp. 1721-1726

2012

  1. Angioplastia primaria en el Área Norte de Galicia: cambios asistenciales y resultados tras la implantación del programa PROGALIAM

    Revista Espanola de Cardiologia, Vol. 65, Núm. 4, pp. 341-349

  2. Renal insufficiency and vascular complications after primary angioplasty via femoral route. Impact of vascular closure devices use

    Revista Espanola de Cardiologia, Vol. 65, Núm. 3, pp. 258-264

2011

  1. Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

    American Heart Journal, Vol. 161, Núm. 6, pp. 1207-1213

2010

  1. Influencia de la trombosis del stent en la relación riesgo-beneficio de los stents farmacoactivos y los stents convencionales

    Revista Espanola de Cardiologia, Vol. 63, Núm. 5, pp. 528-535

2009

  1. Sudden Cardiac Death of Two Heart Transplant Patients With Correctly Functioning Implantable Cardioverter Defibrillators

    Journal of Heart and Lung Transplantation, Vol. 28, Núm. 4, pp. 412-414

2008

  1. Late thrombosis of paclitaxel-eluting stents: Long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients

    American Heart Journal, Vol. 155, Núm. 4, pp. 648-653

2007

  1. Nefropatía inducida por contraste y fracaso renal agudo tras cateterismo cardiaco urgente: Incidencia, factores de riesgo y pronóstico

    Revista Espanola de Cardiologia, Vol. 60, Núm. 10, pp. 1026-1034